Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT02119754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.
Study identification
- NCT ID
- NCT02119754
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- Aug 31, 2014
- Completion
- Aug 31, 2014
- Last update posted
- Sep 24, 2014
2013 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ledesma Foot and Ankle | Phoenix | Arizona | 85032 | — |
| Foot & Ankle Clinic | Los Angeles | California | 90010 | — |
| Samuel Merritt University | Oakland | California | 94609 | — |
| ASAP Urgent-Care | Hamden | Connecticut | 06514 | — |
| Advance Medical Research Center | Miami | Florida | 33135 | — |
| Miami Center for Clinical Research, LLC | Miami | Florida | 33144 | — |
| Unlimited Medical Research, LLC | Miami | Florida | 33144 | — |
| Phoenix Medical Research, LLC | Miami | Florida | 33165 | — |
| Med Research of Florida, LCC | Miami | Florida | 33186 | — |
| Sweet Hope Research Specialty, Inc. | Miami Lakes | Florida | 33016 | — |
| Weil Foot & Ankle Institute | Des Plaines | Illinois | 60016 | — |
| Research Integrity | Owensboro | Kentucky | 42303 | — |
| Paddington Testing Company, Inc | Philadelphia | Pennsylvania | 19103 | — |
| AllCare Foot & Ankle, PA | Arlington | Texas | 76015 | — |
| Coastal Podiatry Group | Virginia Beach | Virginia | 23464 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02119754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2014 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02119754 live on ClinicalTrials.gov.